A year ago, Pfizer Inc (PFE) entered the Red Unfavored Zone of the SIA S&P 100 Index report, with its stock priced at $46.08. Since its entry into the red zone, Pfizer’s stock experienced a significant decline, falling 36.36% over the past year. This downtrend in Pfizer’s stock is in stark contrast to the S&P 500 index, which saw a 22.05% increase over the same period. Currently, Pfizer is now positioned dead last in the SIACharts S&P 100 Index rankings, having dropped 4 spots in the last quarter.
Menu